Jaguar動物健康 JAGX 深 滬
等待開盤 11-26 09:30:00 美东时间
1.24
-0.030
-2.36%
華盛通- 最 高1.25
- 今 開1.11
- 成交量 20.32万股
- 最 低 1.10
- 昨 收 1.27
- 總市值 269.69万
- 52周最高 33.25
- 市盈率 靜 --
- 換手率 9.34%
- 52周最低 1.10
- 委 比 37.06%
- 總股本 217.49万
- 歷史最高 2501887500.00
- 量 比 1.08
- 振 幅 11.81%
- 歷史最低 1.10
- 每 手 1
- 風險率 9.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jaguar Health Submits All Amended Protocol To FDA For Its Current Clinical Studies Of Crofelemer In Pediatric MVID Participants
Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that, in support of a possible expedited approval pathway for crofelemer for treatment of intestinal failure in
11-20 22:04
Jaguar Health Amends Royalty Interests and Note Terms
An announcement from Jaguar Animal Health ( ($JAGX) ) is now available. On Nove...
11-20 02:58
Jaguar Health Q3 EPS $(6.28) Misses $(5.08) Estimate, Sales $3.083M Miss $3.730M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(6.28) per share which missed the analyst consensus estimate of $(5.08) by 23.62 percent. This is a 76.08 percent increase over losses of $(26.25) per share from
11-17 21:04
Jaguar Animal Health Secures $10.8M Note Agreement
An update from Jaguar Animal Health ( ($JAGX) ) is now available. On November 1...
11-15 06:17
Jaguar Health To Present An Abstract With Partial Results From An Ongoing Investigator-Initiated Trial Of Crofelemer Demonstrating Disease Progression Modification And Reduction Of Total Parenteral Support In Pediatric Intestinal Failure Patients Ranging Between 12% To 37%
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of total parenteral support (PS) in pediatric
11-06 22:09
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 28.3% to $0.89 during Thursda...
10-10 05:06
Jaguar Health Reduces Royalty Interest with Stock Exchange
Jaguar Animal Health ( ($JAGX) ) has provided an announcement. On September 30,...
10-04 05:01
Jaguar Animal Health Secures Funding Through Private Placement
Jaguar Animal Health ( ($JAGX) ) has provided an update. On September 28, 2025,...
10-02 04:54
Jaguar Health Says On September 28, Co Entered Securities Purchase Agreement With Brown Stone Capital Limited; Purchase Price Of Shares Is $1.56 Per Share
On September 28, 2025, Jaguar Health, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with Brown Stone Capital Limited (the "Investor"), pursuant to which the Company agreed
10-02 04:22
Jaguar Health's Napo Pharma Submits Orphan Drug Application To FDA For Crofelemer To Treat Diarrhea In Metastatic Breast Cancer Patients On Targeted Therapy
Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis results for crofelemer in the prespecified subgroup of patients with
09-24 21:04
